°ªºÝ¬Ì]ÀòWHOÃÙ§U ±N¦bôÛ¤ñ¨È¶i¦æÁ{§É¹êÅç
2021-09-15
5942
¥xÆW°ªºÝ¬Ì]¦¨¬°¥@¬É½Ã¥Í²Õ´¡]WHO¡^Ô¿ï¬Ì]¼t°Ó¦W³æ«á¡A±N³z¹LWHOÃÙ§Uªº¬Ì]¸ÕÅçpµe¡A¦bôÛ¤ñ¨È¹ï4¸U¦W16·³¥H¤Wªº°ª·ÀI±Ú¸s§ÓÄ@ªÌ¶i¦æÁ{§É¸ÕÅç¡C
ºî¦X³ø¾É¡A¥xÆW°ªºÝ¬Ì]¦¨¬°¥@¬É½Ã¥Í²Õ´¡]WHO¡^Ô¿ï¬Ì]¼t°Ó¦W³æ«á¡A±N³z¹LWHOÃÙ§Uªº¬Ì]¸ÕÅçpµe¡A¦bôÛ¤ñ¨È¹ï4¸U¦W16·³¥H¤Wªº°ª·ÀI±Ú¸s§ÓÄ@ªÌ¶i¦æÁ{§É¸ÕÅç¡C
ôÛ¤ñ¨È°ê®a¹«~ÃÄ«~ºÊ·þºÞ²z§½¡]Invima¡^³ø§i§åã¤F¡u¬Ì]¹ÎÅé¸ÕÅç Vaccine Solidarity Trial¡v¡A³o¬O°w¹ï·s«aªÍª¢Ô¿ï¬Ì]ªº¤@¶µ°ê»Ú©ÊÀH¾÷¸ÕÅç¡A¸Ó¬ã¨s¥ÑWHO©ÒÃÙ§U¡C
ôÛ¤ñ¨È¦b¥þ²y20ÓÔ¿ï°ê®a¤¤³Q¿ï¤¤¡A¨Ã¦¨¬°¬ü¬w¦a°Ï°Ñ»P¸ÓÁ{§É¸ÕÅ窺¤»Ó°ê®a¤§¤@¡F³o¶µ¥þ²y©Ê¸ÕÅç¡A·|³°Äò¥[¤J¨ä¥L¦³¼ç¤Oªº¬Ì]¡A¹wp¥þ²y±N·|¦³12¸U¨ü¸ÕªÌ¡C
¥~´C³ø¾É«ü¥X¡AôÛ¤ñ¨È±N¶i¦æ¨âºØÃþ«¬ªº¬Ì]¸ÕÅç¡A¤@¬O¥Ñ¥xÆW°ªºÝ¤½¥q¶}µoªºMVC-COV190115ªº³J¥Õ¦¸³æ¦ì¬Ì]¡F¥t¤@ºØ«h¬O¥ÑInovio Pharmaceuticals¤½¥q¶}µo¡A¨Ï¥Î²æ®ñ®Ö¿}®Ö»Ä¡]DNA¡^§Þ³NªºINO-4800¬Ì]¡C
³ø¾É´£¨ì¡AôÛ¤ñ¨È±N©Û¶Ò4¸U¦W16·³¥H¤WôÛ¤ñ¨È¨ü¸ÕªÌ°Ñ»P¡A¥H©~¦í¬Ì±¡·ÀI©Ê°ª¦a°ÏªÌ¡BÂåÀø¤u§@ªÌ¡B²Ä¤@½u¤u§@¤Hû¡B©|¥¼±µºØªº¥Á¥Í¥²¶·¤u§@¤Hû¡A¹ê¬I¬°´Á15Ó¤ëÆ[¹î¡C
¡i¹Ï¤ù¬°¸ê®Æ·Ó¡j
ôÛ¤ñ¨È°ê®a¹«~ÃÄ«~ºÊ·þºÞ²z§½¡]Invima¡^³ø§i§åã¤F¡u¬Ì]¹ÎÅé¸ÕÅç Vaccine Solidarity Trial¡v¡A³o¬O°w¹ï·s«aªÍª¢Ô¿ï¬Ì]ªº¤@¶µ°ê»Ú©ÊÀH¾÷¸ÕÅç¡A¸Ó¬ã¨s¥ÑWHO©ÒÃÙ§U¡C
ôÛ¤ñ¨È¦b¥þ²y20ÓÔ¿ï°ê®a¤¤³Q¿ï¤¤¡A¨Ã¦¨¬°¬ü¬w¦a°Ï°Ñ»P¸ÓÁ{§É¸ÕÅ窺¤»Ó°ê®a¤§¤@¡F³o¶µ¥þ²y©Ê¸ÕÅç¡A·|³°Äò¥[¤J¨ä¥L¦³¼ç¤Oªº¬Ì]¡A¹wp¥þ²y±N·|¦³12¸U¨ü¸ÕªÌ¡C
¥~´C³ø¾É«ü¥X¡AôÛ¤ñ¨È±N¶i¦æ¨âºØÃþ«¬ªº¬Ì]¸ÕÅç¡A¤@¬O¥Ñ¥xÆW°ªºÝ¤½¥q¶}µoªºMVC-COV190115ªº³J¥Õ¦¸³æ¦ì¬Ì]¡F¥t¤@ºØ«h¬O¥ÑInovio Pharmaceuticals¤½¥q¶}µo¡A¨Ï¥Î²æ®ñ®Ö¿}®Ö»Ä¡]DNA¡^§Þ³NªºINO-4800¬Ì]¡C
³ø¾É´£¨ì¡AôÛ¤ñ¨È±N©Û¶Ò4¸U¦W16·³¥H¤WôÛ¤ñ¨È¨ü¸ÕªÌ°Ñ»P¡A¥H©~¦í¬Ì±¡·ÀI©Ê°ª¦a°ÏªÌ¡BÂåÀø¤u§@ªÌ¡B²Ä¤@½u¤u§@¤Hû¡B©|¥¼±µºØªº¥Á¥Í¥²¶·¤u§@¤Hû¡A¹ê¬I¬°´Á15Ó¤ëÆ[¹î¡C
¡i¹Ï¤ù¬°¸ê®Æ·Ó¡j
§@ªÌ¤¶²Ð
©µ¦ù¾\Ū